Compass Pathways Announces Second Quarter 2025 Financial Results and Business HighlightsBusiness Wire • 07/31/25
Compass Pathways to Announce Second Quarter Financial Results on July 31, 2025Business Wire • 07/22/25
These 2 Stocks Could More Than Double Your Money, According to Wall Street. Is It Time to Buy?The Motley Fool • 07/20/25
Compass Pathways to Participate in HC Wainwright @Home Series Interview on July 14th, 8:00am ETBusiness Wire • 07/10/25
Compass Pathways Stock: Downgrading To Hold On Released TRD Results With COMP360Seeking Alpha • 06/24/25
Compass Pathways' late-stage psilocybin trial targeting treatment-resistant depression meets primary endpointProactive Investors • 06/23/25
Vizsla Silver, COMPASS Pathways And Other Big Stocks Moving Lower In Monday's Pre-Market SessionBenzinga • 06/23/25
Compass Pathways stock slip as psilocybin depression trial falls short of expectationsInvezz • 06/23/25
Compass Pathways Successfully Achieves Primary Endpoint in First Phase 3 Trial Evaluating COMP360 Psilocybin for Treatment-Resistant DepressionBusiness Wire • 06/23/25
FDA seen likely to grant emergency use authorizations for psychedelics, boosting sector stocksProactive Investors • 06/18/25
COMPASS Pathways (CMPS) Upgraded to Buy: Here's What You Should KnowZacks Investment Research • 05/14/25
Compass Pathways to Participate in 2025 RBC Capital Markets Global Healthcare ConferenceBusiness Wire • 05/14/25
Compass Pathways Announces First Quarter 2025 Financial Results and Business HighlightsBusiness Wire • 05/08/25
Compass Pathways Establishes Strategic Collaboration with HealthPort to Inform the Potential Delivery of COMP360 Synthesized Psilocybin Treatment in Underserved CommunitiesBusiness Wire • 04/29/25
Compass Pathways Announces Dosing Complete for All Participants in Part A of Phase 3 COMP005 Trial of COMP360 Psilocybin for Treatment-Resistant DepressionBusiness Wire • 04/22/25
Compass Pathways Announces Completion of Recruitment for the Phase 3 COMP005 Trial of COMP360 Psilocybin for Treatment-Resistant DepressionBusiness Wire • 03/26/25